Analystenmeinungen

Übersicht

Letzte Communitymeinungen

Ein User hat Moderna abonniert.

Aktionärsstruktur der Moderna

1.362 News & Informationen zur Moderna Aktie

  • Is Moderna Headed for a Breakout? By StockNews
    investing.com

  • QQQA Picks the Best Momentum Companies as the Nasdaq Continues to Hit Records
    etftrends.com

    QQQA Picks the Best Momentum Companies as the Nasdaq Continues to Hit Records

    The Nasdaq closed at another record high on Wednesday as markets continue to…

  • Is Moderna Headed for a Breakout?
    entrepreneur.com

    Is Moderna Headed for a Breakout?

    A level of support and a resistance line have created an ascending triangle in the chart of Moderna, Inc. (MRNA). If the stock breaks through this res…

  • CureVac Aktie kaufen: Setzt sich die Erholungsrallye bei CureVac fort?
    etf-nachrichten.de

    CureVac Aktie kaufen: Setzt sich die Erholungsrallye bei CureVac fort?

    Zum Abschluss der Handelswoche notiert die CureVac Aktie rund 2 % im Plus. Damit gehört man zu den Gewinnern des heutigen Handelstages. Doch noch besser lässt sich die Performance der letzten sieben Tage sehen. Denn in nur einer Woche gab es ein Kursplus von rund 7 %. Damit schreitet die Erholung nach dem Aktiencrash weiter […]

  • Japan Vaccination Drive Faces Possible Setback Due to Contaminated Batch
    insurancejournal.com

    Japan Vaccination Drive Faces Possible Setback Due to Contaminated Batch

    A contaminant found in a batch of Moderna Inc.'s COVID-19 vaccines delivered to Japan is believed to be a metallic particle, Japanese public broadcaster

  • Positive Economic Signals Overpower Demand Concerns
    rigzone.com

    Positive Economic Signals Overpower Demand Concerns

    Rigzone's regular market watchers look at the oil price rebound, demand indicators, the effect of a Gulf of Mexico platform fire and more.

  • Is It Time To Buy Moderna?
    investing.com

    Is It Time To Buy Moderna?

    Stocks Analysis by Investing.com (Haris Anwar/Investing.com) covering: S&P 500, Bristol-Myers Squibb Company, CVS Health Corp, GlaxoSmithKline PLC ADR. Read Investing.com (Haris Anwar/Investing.com)'s latest article on Investing.com

  • Contaminant in Moderna vaccines suspected to be metallic particles -NHK By Reuters
    investing.com

    Contaminant in Moderna vaccines suspected to be metallic particles -NHK By Reuters

    Contaminant in Moderna vaccines suspected to be metallic particles -NHK

  • Evening Update: At least 72 dead in Kabul airport attack, including 12 U.S. troops; Ryerson University decides to change name
    theglobeandmail.com

    Evening Update: At least 72 dead in Kabul airport attack, including 12 U.S. troops; Ryerson University decides to change name

    Plus, the federal election campaign enters Day 12

  • Y-Intercept (Hong Kong) Ltd Buys Linde PLC, Moderna Inc, Qualcomm Inc, Sells Baidu Inc, Kimberly-Clark Corp, Moody's Corporation
    gurufocus.com

    Y-Intercept (Hong Kong) Ltd Buys Linde PLC, Moderna Inc, Qualcomm Inc, Sells Baidu Inc, Kimberly-Clark Corp, Moody's Corporation

    GuruFocus Article or News written by insider and the topic is about:

  • Delta Variant Could Dent Economy
    etftrends.com

    Delta Variant Could Dent Economy

    This is happening against the backdrop of rising inflation and typical seasonal challenges for stocks, but…

  • Moderna-Aktie in Rot: Japan zieht 1,6 Millionen Moderna-Impfdosen zurück
    finanzen.net

    Moderna-Aktie in Rot: Japan zieht 1,6 Millionen Moderna-Impfdosen zurück

    Japan zieht gut 1,6 Millionen Dosen des COVID-19-Impfstoffs von Moderna aus dem Verkehr. 26.08.2021

  • Moderna (MRNA) Seeks Full FDA Approval for COVID-19 Vaccine
    zacks.com

    Moderna (MRNA) Seeks Full FDA Approval for COVID-19 Vaccine

    Moderna (MRNA) completes rolling submission of BLA to the FDA seeking full approval of its COVID-19 vaccine candidate, mRNA-1273, in the United States.

  • U.S. COVID-19 hospitalizations hit 100,000 to mark highest level since January
    marketwatch.com

    U.S. COVID-19 hospitalizations hit 100,000 to mark highest level since January

    The number of COVID-19 hospitalizations in the U.S. has been slowly ticking up, and new data shows that 100,000 people are currently hospitalized with…

  • BioNTech’s Capabilities Questionable, Despite Vaccine Victory By TipRanks
    investing.com

    BioNTech’s Capabilities Questionable, Despite Vaccine Victory By TipRanks

    BioNTech’s Capabilities Questionable, Despite Vaccine Victory

  • Pfizer, BioNTech expand covid-19 vaccine manufacturing into Latin America
    livemint.com

    Pfizer, BioNTech expand covid-19 vaccine manufacturing into Latin America

    Deal would allow Brazil’s Eurofarma to produce at least 100 million doses annually for distribution in the region

  • Politicians getting third Covid jab as most Indonesians unvaccinated
    businessmirror.com.ph

    Politicians getting third Covid jab as most Indonesians unvaccinated

    Political elites in Indonesia are admitting to getting a third dose of Covid-19 vaccines, defying calls from the health ministry as most of the country have not received even their first shot. Military Chief Hadi Tjahjanto and East Kalimantan Governor Isran Noor said during a meeting with President Joko Widodo…

  • A Peek Into The Markets: US Stock Futures Edge Lower; Jackson Hole Event In Focus
    benzinga.com

    A Peek Into The Markets: US Stock Futures Edge Lower; Jackson Hole Event In Focus

    Pre-open movers
    U.S. stock futures traded slightly lower in early pre-market trade after the S&P 500 and Nasdaq surged to record highs in the previous …

  • 10 Stocks With Strong Media Sentiment In August 2021
    investing.com

    10 Stocks With Strong Media Sentiment In August 2021

    Stocks Analysis by MarketBeat.com (Chris Markoch) covering: Microsoft Corporation, Walt Disney Company, Apple Inc, Pfizer Inc. Read MarketBeat.com (Chris Markoch)'s latest article on Investing.com

  • Biontech, Standard Lithium, Nel,Varta – viermal analysiert…
    feingold-research.com

  • Diversifizierte Biotechnologie mit Dividende in einem Wert
    divantis.de

    Diversifizierte Biotechnologie mit Dividende in einem Wert

    Warum die Aktie von BB Biotech für mich die perfekte Investition im Biotechnologie-Sektor ist: Mehrere Titel zugleich, verteilte Risiken und eine hohe Dividende.

  • Moderna withholds 1.63 mln COVID-19 vaccine doses in Japan due to contamination
    financialpost.com

    Moderna withholds 1.63 mln COVID-19 vaccine doses in Japan due to contamination

    Moderna Inc said on Wednesday it has withheld supply of about 1.63 million doses of its COVID-19 vaccine in Japan after a report of contamination of vials with…

  • Dollar Up, But Near One-Week Low as COVID-19 Concerns Ease By Investing.com
    investing.com

    Dollar Up, But Near One-Week Low as COVID-19 Concerns Ease By Investing.com

    Dollar Up, But Near One-Week Low as COVID-19 Concerns Ease

  • U.S. likely to approve COVID-19 boosters at 6 months after vaccination
    marketwatch.com

    U.S. likely to approve COVID-19 boosters at 6 months after vaccination

    Federal regulators are likely to approve a COVID-19 booster shot for vaccinated adults starting at least six months after the previous dose rather than the…

  • Moderna withholds 1.63 mln COVID-19 vaccine doses in Japan due to contamination
    financialpost.com

    Moderna withholds 1.63 mln COVID-19 vaccine doses in Japan due to contamination

    Moderna Inc has withheld supply of about 1.63 million doses in Japan after it was notified of contamination of its COVID-19 vaccine vials with particulate…

  • U.S. plans COVID-19 booster shots at six months instead of eight - WSJ
    financialpost.com

    U.S. plans COVID-19 booster shots at six months instead of eight – WSJ

    U.S. health regulators could approve a third COVID-19 shot for adults beginning at least six months after full vaccination, instead of the previously announced…

  • Heart inflammation risk boosted slightly by vaccine, more by COVID-19
    investing.com

    Heart inflammation risk boosted slightly by vaccine, more by COVID-19

    Heart inflammation risk boosted slightly by vaccine, more by COVID-19 – study

  • U.S. set to approve COVID-19 booster shots at six months: WSJ
    economiccollapsenews.com

  • Moderna : Heart inflammation risk boosted slightly by vaccine, more by COVID-19 -study
    marketscreener.com

    Moderna : Heart inflammation risk boosted slightly by vaccine, more by COVID-19 -study

    The use of Pfizer Inc and German
    partner BioNTech SE's widely used COVID-19 vaccine
    marginally increases the risk of heart inflammation, but the
    risk is higher among those infected with the… | August 25, 2021

  • Pfizer seeks U.S. approval for COVID vaccine booster
    financialpost.com

    Pfizer seeks U.S. approval for COVID vaccine booster

    Pfizer Inc on Wednesday said a booster dose of its two-shot COVID-19 vaccine spurs a more than threefold increase in antibodies against the coronavirus, as the…

  • Moderna : U.S. plans COVID-19 booster shots at six months instead of eight - WSJ
    marketscreener.com

    Moderna : U.S. plans COVID-19 booster shots at six months instead of eight – WSJ

    U.S. health regulators could approve a
    third COVID-19 shot for adults beginning at least six months
    after full vaccination, instead of the previously announced
    eight-month gap, the Wall Street Journal… | August 25, 2021

  • Unused Moderna COVID-19 vaccines contained foreign material - Japan (NASDAQ:MRNA)
    seekingalpha.com

    Unused Moderna COVID-19 vaccines contained foreign material – Japan (NASDAQ:MRNA)

    Japan has withdrawn 1.6M doses of COVID-19 vaccine developed by Moderna (MRNA) due to contamination, the country’s Ministry of Health, Labor and Welfare says, according to…

  • Moderna Stock Will Significantly Exceed Projections (NASDAQ:MRNA)
    seekingalpha.com

    Moderna Stock Will Significantly Exceed Projections (NASDAQ:MRNA)

    Based on management revenue and expense guidance, Moderna should achieve EPS of $28.50-$30.00 in 2021. For 2022, the consensus has recently moved up from $19.00 to $26.00, I am at $37.

  • BioNTech, Pfizer initiate application for approval of a third dose of their COVID-19 vaccine
    marketwatch.com

    BioNTech, Pfizer initiate application for approval of a third dose of their COVID-19 vaccine

    BioNTech SE undefined and Pfizer Inc. undefined said Wednesday that they initiated an application to U.S. regulators for a third dose of Comirnaty, their…

  • Best Buy Among Today’s Trending Stocks As Indices Trend Upward
    forbes.com

    Best Buy Among Today’s Trending Stocks As Indices Trend Upward

    Q.ai runs daily factor models to get the most up-to-date reading on stocks and ETFs. Today, our deep-learning algorithms have identified Best Buy among others.

  • Moderna wraps full FDA approval request of COVID-19 vaccine
    news.google.com

    Moderna wraps full FDA approval request of COVID-19 vaccine

    Moderna has completed a submission filing for full FDA approval of its COVID-19 vaccine in individuals 18 and up.

  • Moderna completes filing process for full approval of COVID-19 vaccine
    financialpost.com

    Moderna completes filing process for full approval of COVID-19 vaccine

    Moderna Inc has completed the real-time review process needed for a full approval for its COVID-19 vaccine in people aged 18 years and above, the company said…

  • +++Börsen-Ticker+++ - Wall Street verliert an Schwung - Tech-Rally geht weiter
    cash.ch

    +++Börsen-Ticker+++ – Wall Street verliert an Schwung – Tech-Rally geht weiter

    US-Technologieaktien bleiben auf Rekordjagd.

  • Moderna completes BLA submission for full approval of COVID-19 vaccine
    marketwatch.com

    Moderna completes BLA submission for full approval of COVID-19 vaccine

    Shares of Moderna Inc. undefined rallied 4.0% in morning trading Wednesday after the biotechnology company said it has completed the submission to the Food…

  • J&J says an extra dose of its COVID-19 vaccine can boost antibody levels
    marketwatch.com

    J&J says an extra dose of its COVID-19 vaccine can boost antibody levels

    Johnson & Johnson is the latest drug maker to make the case that an extra dose of its COVID-19 shot can help boost antibody levels—by at least nine times…

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Moderna Aktie

Das Unternehmen Moderna aus USA ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.

Moderna ist in mehr als 39 ETFs enthalten und somit eine vermutlich durchschnittlich bekannte Aktie. Der Spitzenreiter iShares Nasdaq US Biotechnology  UCITS  ETF gewichtet Moderna mit 12,47% im ETF.

Entdecke die 6 ETFs in denen Moderna am höchsten gewichtet ist Insgesamt in 39 ETFs enthalten

Dir gefallen die Informationen zu Moderna?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Moderna?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Moderna?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Moderna?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect